 |
|
|
|
 |
|
|
| Article 1 to 10 out of 13 concerning QIAGEN GmbH
|
-
EU Launches Project to Improve In-Vitro Diagnostics
(14 Jan 2009)
QIAGEN led-consortium to develop standards for patient sample processing in order to facilitate the discovery and prediction of diseases
The European Union launched a new research project targeting to expand the potentials and utility of in-vitro diagnostics through the creation of new standards for the collection, handling and processing of blood, tissue, tumor and other sample ...
-
QIAGEN Recognized as One of the Best Companies to Work for in Life Science Industry
(08 May 2007)
Award is the latest in a series of national and international recognitions recognizing QIAGEN as a leading employer
QIAGEN N.V. announced that it has been recognized as one of the best places to work for in Life Sciences. The recognition was awarded on April 30 by "The Scientist". In its 5th annual "Best Places to Work in Industry" Award the magazine surveyed ...
-
QIAGEN Introduces New Tissue Management Standards Targeting Biomedical Cancer Research
(08 Nov 2006)
Standardization in the processing and archiving of tissue samples facilitates new developments in diagnostics and therapeutics
QIAGEN introduced its new Biomedical Tissue Management System. At the BIO Europe 2006 conference, QIAGEN's CEO Peer Schatz, presented a comprehensive set of integrated solutions which shall standardize the entire workflow for the processing of ...
-
QIAGEN Announces Supply Agreement to Provide Preanalytical Solutions to Osmetech Molecular Diagnostics
(22 Nov 2005)
QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. and Osmetech Molecular Diagnostics., a division of Osmetech plc announced that they have entered into a distribution agreement. Pursuant to this agreement, Osmetech will incorporate certain ...
-
QIAGEN collaborates with Institute Curie to develop high-throughput RNAi tools
(11 Oct 2005)
QIAGEN and Institut Curie announced today a collaboration to develop tools for high-throughput RNAi screening as part of the Institut Curie BioPhenics project. This project, led by Drs Jacques Camonis and Franck Perez, aims to use RNAi technology in ...
-
QIAGEN collaborates with the US National Cancer Institute to develop validated siRNAs for cancer genes
(02 Jun 2005)
QIAGEN and the US National Cancer Institute (NCI) have entered into a research agreement to develop a validated set of siRNAs for use by NCI cancer researchers. "QIAGEN is pleased to be able to collaborate with the NCI on this project" said Eric ...
-
QIAGEN Acquires artus GmbH
(01 Jun 2005)
QIAGEN N.V. announced that its wholly owned subsidiary QIAGEN GmbH has entered into a definitive agreement to acquire artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH, an established leader in PCR-based molecular diagnostic ...
-
QIAGEN Announces Supply Agreement With Roche Molecular Systems
(14 Feb 2005)
QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. announced that they have entered into a manufacturing and supply agreement with Roche Molecular Systems, a unit of Roche Diagnostics Basel, Switzerland, who will market QIAGEN's media sample ...
-
QIAGEN and Protedyne Enter Collaboration to Develop Nucleic Acid Purification Solution for Ultra High-Throughput Molecular Diagn
(14 Jun 2004)
Venlo and Windsor QIAGEN and Protedyne Corporation, a premier supplier of industrial robotics for research, drug discovery and testing laboratories, announced that they have entered into a collaboration to develop a fully automated ultra ...
-
QIAGEN appoints Wolfgang Fries as Vice President Global Human Resources
(04 May 2004)
Venlo, The Netherlands - QIAGEN, N.V. announced that Wolfgang Fries has joined QIAGEN and has assumed responsibility for QIAGEN's world wide human resource management as Vice President Global Human Resources starting April 1, 2004. Mr. Fries will be ...
Additional information
QIAGEN GmbH
Hilden, Germany
Company
Products
|
|
|
|
|
|
Top
